UnknownNot Applicable

Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC

China114 participantsStarted 2016-01

Plain-language summary

The study aims to compare the perioperative and long-term outcomes of liver resection for HBV-related HCC with versus without hepatic inflow occlusion.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Elective liver resection due to HBV-related HCC with Barcelona-Clinic Liver Cancer (BCLC) staging 0 or A;
✓. Child-Pugh classified A with or without cirrhosis, or reversed to A from B after conventional therapy;
✓. Tumors located either in the left or right hemiliver;
✓. Resection extent was a hemi-hepatectomy or less;
✓. Informed consent.

Exclusion criteria

✕. Having comorbidity that contraindicates surgery;
✕. Participation in concurrent interventional trials with interference to this study;
✕. Eligible for laparoscopic hepatectomy;
✕. Requiring concomitant procedures, such as digestive, vascular or biliary reconstruction;
✕. Lack of compliance for treatment or future follow-up.

What they're measuring

Serum total bilirubin on postoperative day 5

Timeframe: 5 days

Trial details

NCT IDNCT02563158

SponsorChinese PLA General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-01

Contact for this trial

Shichun Lu, MD, PhD

+86 10 68160801 sclu_301@163.com

View on ClinicalTrials.gov More Liver Cancer trials